Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedAdded glossary term: Mucopolysaccharidosis, MPS-II. Removed glossary term: Mucopolysaccharidosis type 2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page now shows Revision: v3.5.0. The previous Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor maintenance update and does not affect study content or eligibility details.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page shows a minor site revision from v3.4.0 to v3.4.1 with no changes to the study content, eligibility criteria, or reported outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.